Loading...

Home
ETF
MPLT

MPLT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

MPLT News

Aktis Oncology Launches $200 Million IPO with $100 Million Investment from Eli Lilly

Jan 09 2026renaissancecapital

MapLight Accelerates Phase 2 Trial Timelines for Schizophrenia and Autism Studies

Jan 09 2026Globenewswire

MapLight Therapeutics Receives FDA Fast Track Designation for ML-007C-MA in Alzheimer's Treatment

Jan 05 2026NASDAQ.COM

MapLight Receives FDA Fast Track Designation for ML-007C-MA in Alzheimer's Disease Psychosis

Jan 05 2026Globenewswire

MapLight Receives FDA Fast Track Designation for ML-007C-MA in Alzheimer's Disease Psychosis

Jan 05 2026Newsfilter

Aktis Oncology Files for IPO in the U.S. Targeting $346 Million in Funding

Dec 19 2025Newsfilter

MapLight Therapeutics and SandboxAQ Partner to Create Treatments for Central Nervous System Disorders

Dec 16 2025Yahoo Finance

SandboxAQ and MapLight Collaborate on $200M CNS Therapy Development

Dec 16 2025Globenewswire

SandboxAQ and MapLight Collaborate on CNS Therapies with Potential $200M in Milestones

Dec 16 2025Newsfilter

MapLight Therapeutics Raises $296.5 Million in IPO, Funding Secured Through 2027

Dec 04 2025Globenewswire

MapLight to Announce Schizophrenia Trial Findings in Second Half of 2026

Dec 04 2025NASDAQ.COM

Marvell Reports Impressive Q3 Earnings, Alongside American Eagle, Microchip Technology, Box, and Other Major Stocks Rising on Wednesday

Dec 03 2025Benzinga

IBM Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Friday

Nov 21 2025Benzinga

Leerink Partners Begins Coverage of MapLight Therapeutics with Outperform Rating and Sets Price Target at $30

Nov 21 2025Benzinga

Stifel Begins Coverage of MapLight Therapeutics with a Buy Rating and Sets Price Target at $28

Nov 21 2025Benzinga

Morgan Stanley Begins Coverage of MapLight Therapeutics with an Overweight Rating and Sets Price Target at $34

Nov 21 2025Benzinga